Echosens

• European Commission

  HORIZON-JU-RIA, A Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy, 101132901, 2024–2030, 27 Nov 2023

• European Commission

  HORIZON-JU-RIA, GRIP on MASH: Global Research Initiative for Patient Screening on MASH, 101132946, 2023–2027, 27 Nov 2023

Sources: cordis.europa.eu

• Hepatic Steatosis and Cardiovascular Risk in Obesity: A 10-Year Follow-Up Study From Childhood Into Young Adulthood

  Consulting or advice, 1 Sept 2026

• Semaglutide in Japanese participants with metabolic dysfunction-associated steatohepatitis: a subgroup analysis of the ESSENCE trial

  Grants or research support, 28 Aug 2026

• The Malaysian Society of Gastroenterology and Hepatology Consensus Statements on Prevention and Early Detection of Hepatocellular Carcinoma in Malaysia

  Fees or honoraria, 14 Aug 2026

• Cost-Effectiveness of MASH Diagnosis and Management Approaches Among Those With Type 2 Diabetes

  Fees or honoraria, Grants or research support, 3 Nov 2025

• Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

  Consulting or advice, Fees or honoraria, 10 Oct 2022

• Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial

  Consulting or advice, Fees or honoraria, Board or leadership role, 6 Aug 2021

Sources: pubmed.ncbi.nlm.nih.gov

• Liver steatosis and cognitive performance in aging: A pilot cross-sectional study

  Clinical imaging, 18 Jul 2026

• Adipose-Tissue Insulin Resistance Predicts Mortality in Persons at Risk for Cardiac Diseases

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025

• Blood-Flow Restriction Resistance Training Improves Muscle Mitochondrial Function in Type 2 Diabetes

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025